To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Robocath lands $43m Series C
France and UK-based Robocath, a provider of cardiovascular robotic systems for the treatment of vascular diseases, has secured $43 million in Series C financing.
